These included pro-inflammatory cytokines within our CBA panel (IL-6, IL-8, MCP-1, IP-10, RANTES, ICAM-1 and VCAM-1), and factors not in our cytokine CBA panel but implicated in ALS (MMP9, angiogenin, angiopoietin-2, VEGF, uPAR) [44–47]. The gene discussed is CXCL8; the disease is amyotrophic lateral sclerosis.